Medicare Enrolled
Dr. Sahil Bakshi, DO
Cardiovascular Disease · Plano, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bakshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bakshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bakshi
Dr. Sahil Bakshi is a cardiovascular disease specialist in Plano, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bakshi performed 4,986 Medicare services across 3,709 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bakshi received a total of $172,751 from 45 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bakshi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in TX
$172,751 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,986
Medicare services
Top 16% in TX for cardiovascular disease
3,709
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~249 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
791 | $6 | $30 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
670 | $7 | $41 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
667 | $10 | $51 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
655 | $86 | $238 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
507 | $134 | $729 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
464 | $43 | $225 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
173 | $4 | $26 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
160 | $48 | $258 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
103 | $56 | $539 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
100 | $327 | $1,599 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
95 | $8 | $17 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
74 | $151 | $858 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $111 | $310 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $58 | $168 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 60 | $316 | $1,211 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
54 | $61 | $186 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
48 | $1,057 | $4,869 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
48 | $34 | $346 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $125 | $335 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $73 | $301 |
| New patient office visit, complex (60-74 min) | 18 | $126 | $409 |
| Heart muscle strain imaging | 17 | $9 | $139 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $2 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $137 | $517 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $91 | $268 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $69 | $212 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $70 | $361 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
13 | $9 | $96 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
12 | $20 | $98 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.2% high complexity
20.9% medium
68.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$172,751
Total received (2018-2024)
Avg $24,679/year across 7 years
Top 3% in TX for cardiovascular disease
45
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165,000 (95.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,529 (4.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$222 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$28,676
2023
$25,339
2022
$18,998
2021
$12,280
2020
$17,339
2019
$38,635
2018
$31,484
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Actelion Pharmaceuticals US, Inc.
$106,681
United Therapeutics Corporation
$29,802
Bayer HealthCare Pharmaceuticals Inc.
$25,234
Bayer Healthcare Pharmaceuticals Inc.
$4,209
Novartis Pharmaceuticals Corporation
$1,665
Astellas Pharma US Inc
$558
Novo Nordisk Inc
$548
Merck Sharp & Dohme LLC
$485
Janssen Pharmaceuticals, Inc
$393
Amgen Inc.
$274
Janssen Research & Development, LLC
$222
HeartFlow, Inc.
$221
E.R. Squibb & Sons, L.L.C.
$201
Amarin Pharma Inc.
$190
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$189
Inari Medical, Inc.
$186
PFIZER INC.
$171
AstraZeneca Pharmaceuticals LP
$158
Esperion Therapeutics, Inc.
$142
Getinge USA Sales, LLC
$121
SANOFI-AVENTIS U.S. LLC
$93
Boston Scientific Corporation
$88
Merck Sharp & Dohme Corporation
$73
Medtronic Vascular, Inc.
$71
Regeneron Healthcare Solutions, Inc.
$70
Alnylam Pharmaceuticals Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
Inspire Medical Systems, Inc.
$63
Impulse Dynamics (USA) Inc.
$62
Gilead Sciences, Inc.
$58
Kiniksa Pharmaceuticals International, plc
$58
Abbott Laboratories
$44
Siemens Medical Solutions USA, Inc.
$43
Sandoz Inc.
$42
Baxter Healthcare
$38
Acarix USA Inc.
$28
Allergan Inc.
$23
Cook Medical LLC
$19
Kiniksa Pharmaceuticals, Ltd.
$17
BOSTON SCIENTIFIC CORPORATION
$15
Chiesi USA, Inc.
$13
Arbor Pharmaceuticals, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Daiichi Sankyo Inc.
$13
Althera Pharmaceuticals LLC
$10
Top 3 companies account for 93.6% of total payments
Associated products mentioned in payments ›
Acrobat-I Stabilizer · Adempas · Arcalyst · BELSOMRA · BRILINTA · BYSTOLIC · Biograph mCT X-4R · CADScor System · CAMZYOS · CARDENE · CONFIRM RX · Corlanor · ELIQUIS · ENTRESTO · Edarbyclor · FARXIGA · FFRct · FLOWTRIEVER CATHETER · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · INSPIRE · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · Letairis · Lexiscan · LifeVest · Livalo · MULTAQ · Micra · NEXLETOL · NEXLIZET · NONE · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REMODULIN · RYBELSUS · Repatha · Roszet · Rybelsus · S · SOMATOM Pro.Pulse · TREPROSTINIL · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Verquvo · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · XARELTO · ZILVER PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in TX.
Equivalent to $3,465 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
284
Per 100K population
25.4
County median income
$117,588
Nearest hospital
CHILDRENS MEDICAL CENTER PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bakshi is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bakshi experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Bakshi performed 791 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bakshi receive payments from pharmaceutical companies?
Yes. Dr. Bakshi received a total of $172,751 from 45 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bakshi's costs compare to other cardiologists in Plano?
Dr. Bakshi's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bakshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Plano
Browse cardiologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
United Therapeutics Corporation Payments to Doctors
See all physicians who received payments from United Therapeutics Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology